Compositions and methods for detecting human pegivirus 2 (HPgV-2)
AssigneesAbbott Laboratories, The Regents of the University of California
InventorsCharles Chiu, Deanna Lee, Michael Berg, George Dawson, Kelly Coller, Kevin Cheng, John R. Hackett, Jr., Matthew Frankel, Kenn Forberg
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions, methods, and kits for detecting human Pegivirus 2 (HPgV-2). In certain embodiments, provided herein are HPgV-2 specific nucleic acid probes and primers, and methods for detecting HPgV-2 nucleic acid. In other embodiments, provided herein are HPgV-2 immunogenic composition compositions, methods of treating a subject with immunogenic HPgV-2 peptides, and methods of detecting HPgV-2 subject antibodies in a sample.
Claims37
A composition comprising a synthetic DNA nucleic acid molecule,
- wherein said synthetic DNA nucleic acid molecule comprises a nucleotide sequence at least 12 nucleotides in length that hybridizes under stringent conditions to a portion of an HPgV-2 genomic sequence selected from the group consisting of:
- the NS2 gene, the 5′ UTR, the S gene, the E1 gene, the E2 gene, the NS4a gene, the NS4b gene, and the 3′ UTR, and
- wherein said genomic sequence of HPgV-2 is shown in SEQ ID NO:1, 75, or 299-303.
A composition comprising a synthetic nucleic acid molecule,
- wherein said synthetic nucleic acid molecule comprises a nucleotide sequence at least 12 nucleotides in length that hybridizes under stringent conditions to a portion of an HPgV-2 genomic sequence selected from the group consisting of:
- the NS2 gene, the 5′ UTR, the S gene, the E1 gene, the E2 gene, the NS4a gene, the NS4b gene, and the 3′ UTR, and wherein said genomic sequence of HPgV-2 is shown in SEQ ID NO:
- 1, 75, or 299-303;
- wherein the synthetic nucleic acid molecule is linked to a fluorescent label, chemiluminescent label or enzymatic label, a heterologous nucleic acid sequence or a solid support or the synthetic nucleic acid molecule comprises at least one modified base selected from the group consisting of:
- phosphorothioate, boranophosphate, 4′-thio-ribose, locked nucleic acid, 2′-0-(2′-methoxyethyl), 2′-0-methyl, 2′-fluoro, 2′-deoxy-T-fluoro-b-D-arabinonucleic acid, phosphonoacetate, 2′-3′-seco-RNA, Morpholino nucleic acid analog, Peptide nucleic acid analog, phosphorodithioate, phosphoramidate, methylphosphonate, 4-acetylcytosine, 8-hydroxy-N6-methyladenosine, aziridinylcytosine, pseudoisocytosine, 5-(carboxyhydroxylmethyl)uracil, 5-fluorouracil, 5-bromouracil, 5-carboxymethylaminomethyl-2-thiouracil, 5-carboxymethylaminomethyluracil, dihydrouracil, inosine, N6-isopentenyladenine, 1-methyladenine, 1-methylpseudouracil, 1-methylguanine, 1-methylinosine, 2,2-dimethylguanine, 2-methyladenine, 2-methylguanine, 3-methylcytosine, 5-methylcytosine, N6-methyladenine, 7-methylguanine, 5-methylaminomethyluracil, 5-methoxy-aminomethyl-2-thiouracil, beta-D-mannosylqueosine, 5′-methoxycarbonylmethyluracil, 5-methoxyuracil, 2-methylthio-N6-isopentenyladenine, uracil-5-oxyacetic acid methylester, uracil-5-oxyacetic acid, oxybutoxosine, pseudouracil, queosine, 2-thiocytosine, 5-methyl-2-thiouracil, 2-thiouracil, 4-thiouracil, 5-methyluracil, N-uracil-5-oxyacetic acid methylester, uracil-5-oxyacetic acid, pseudouracil, queosine, 2-thiocytosine, 2,6-diaminopurine, 2-aminopurine, 5-amino-allyluracil, 5-hydroxymethylcytosine, 5-iodouracil, 5-nitroindole, 5-propynylcytosine, 5-propynyluracil, hypoxanthine, N3-methyluracil, N6,N6-dimethyladenine, purine, C-5-propynyl cytosine, C-5-propynyl uracil, and difluorotouyl.
Dependencies are inferred from the claim text.